Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-center, Single-arm Clinical Study to Evaluate the Safety and Effectiveness of Percutaneous Intramyocardial Septal Radiofrequency Ablation System in the Treatment of Hypertrophic Obstructive Cardiomyopathy

NCT06277960 is registered in ClinicalTrials.gov with SuZhou Sinus Medical Technologies Co.,Ltd as lead sponsor.

NCT NCT06277960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-center, Single-arm Clinical Study to Evaluate the Safety and Effectiveness of Percutaneous Intramyocardial Septal Radiofrequency Ablation System in the Treatment of Hypertrophic Obstructive Cardiomyopathy
Lead sponsor
SuZhou Sinus Medical Technologies Co.,Ltd
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 28, 2024
Completion date
June 30, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic obstructive cardiomyopathy (hocm)